| ²é¿´: 5841 | »Ø¸´: 20 | ||||
| µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû | ||||
Newsר¼Ò¹ËÎÊ (Ö°Òµ×÷¼Ò)
|
[ÇóÖú]
EP¶ÔÕÕÆ·´¿¶ÈÎÊÌâ
|
|||
|
ÎÒÃÇÂòÁËÁ½ÖÖEP¶ÔÕÕÆ·£¬½á¹ûÆ¿×ӺͶÔÕÕÆ·ÎļþÉÏÃæÎ´±êÃ÷¶ÔÕÕÆ·µÄ´¿¶È£¬Ñ¯ÎÊ´úÀíÉÌ£¬ËûÃÇÒ²²»ÖªµÀ¡£²»ÖªµÀÓÐľÓгæÓÑÅöµ½¹ýÕâÖÖ×´¿öÄØ£¿ÄãÃÇÊÇÔõô½â¾öµÄ£¿ Èç¹û£¬ÓÐÎÄÏ××ÊÁÏÇëÉÏ´«ÎÄÏ××ÊÁÏ£¬ |
» ÊÕ¼±¾ÌûµÄÌÔÌûר¼ÍƼö
New Drug Research and Development | »Ø¸´ |
» ²ÂÄãϲ»¶
Õ»۵ȱàÖøµÄ¡¶Åäλ»¯Ñ§£ºÔÀíÓëÓ¦Óá·
ÒѾÓÐ1È˻ظ´
ÇóÖú£¡£¡£¡´óÀоÈÃü£¡£¡£¡
ÒѾÓÐ4È˻ظ´
Ò©ÎïѧÂÛÎÄÈóÉ«/·ÒëÔõôÊÕ·Ñ?
ÒѾÓÐ90È˻ظ´
õ£°·ËõºÏ
ÒѾÓÐ3È˻ظ´
ҩѧר˶µ÷¼Á
ÒѾÓÐ2È˻ظ´
ҩѧѧ˶326Çóµ÷¼Á
ÒѾÓÐ1È˻ظ´
105500ҩѧµ÷¼Á£¬Ò»Ö¾Ô¸¶¥9£¬Ö÷³ÖÊ¡¼¶´ó´´£¬ÊµÑéÐÍSCI¶þ×÷£¬ËÄÁù¼¶Òѹý£¬Ë«¹ú½±
ÒѾÓÐ6È˻ظ´
ҩѧר˶µ÷¼Á
ÒѾÓÐ0È˻ظ´
publcifµÄʹÓÃ
ÒѾÓÐ0È˻ظ´
Çóµ÷¼Á
ÒѾÓÐ2È˻ظ´
»á¼Æ×¨Ë¶Çóµ÷¼Á
ÒѾÓÐ0È˻ظ´
» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:
ÑÎËá½ð¸ÕÍé°·µÄÒºÏàÇóÖú
ÒѾÓÐ5È˻ظ´
»¯Ò© ×ÔÖÆ¶ÔÕÕÆ·
ÒѾÓÐ11È˻ظ´
ÖÐÒ©Ñз¢¹ý³ÌÖеķÇÖмìËù¶ÔÕÕÆ·ÎÊÌâ
ÒѾÓÐ8È˻ظ´
ÈçºÎ ½øÐбê×¼±È¶ÔÑо¿
ÒѾÓÐ13È˻ظ´
×ÔÖ÷±ê¶¨µÄ¶ÔÕÕÆ·²âÔÁÏÒ©º¬Á¿Æ«µÍ
ÒѾÓÐ5È˻ظ´
ÖмìËù±êÆ·º¬Á¿µÄÎÊÌâ
ÒѾÓÐ9È˻ظ´
EP/USP¶ÔÕÕÆ·ÓÐЧÆÚÈçºÎ²éѯ£¿
ÒѾÓÐ14È˻ظ´
CTD¸ñʽÀïµÄS.5¶ÔÕÕÆ·µÄÒªÇó
ÒѾÓÐ8È˻ظ´
Òì¹¹Ìå¼ì²â·½·¨ÑéÖ¤Ôõô×ö
ÒѾÓÐ13È˻ظ´
΢Á¿ÑùƷø´ß»¯Ê±ÓÃʲôװÖã¿ë²Æø±£»¤Çé¿öÏÂÔõô½øÐвúÎïµÄ¼ì²â£¿
ÒѾÓÐ3È˻ظ´
¶ÔÕÕÆ·Óë±ê×¼Æ·Çø±ð£¿
ÒѾÓÐ4È˻ظ´
ÖÐҩijÖֳɷֵĺ¬Á¿²â¶¨·½·¨Ñ§¿¼²ì ÏßÐÔŨ¶ÈÎÊÌâ
ÒѾÓÐ6È˻ظ´
¡¾ÇóÖú¡¿Ò©µäδÁгöµÄÔÓÖÊÎÞ·¨Ìṩ¶ÔÕÕÆ·£¬Ôõô°ì£¿
ÒѾÓÐ8È˻ظ´
Ò©Îï·ÖÎöһЩÑéÖ¤ÎÊÌâ
ÒѾÓÐ8È˻ظ´
Çë½Ì·½·¨Ñ§ÑéÖ¤µÄ¼¸¸öÎÊÌâ
ÒѾÓÐ25È˻ظ´
º¬Á¿²â¶¨·½ÃæµÄÎÊÌâ
ÒѾÓÐ6È˻ظ´
¡¾ÇóÖú¡¿¹ØÓÚ¹¤×÷¶ÔÕÕÆ·µÄ±ê¶¨
ÒѾÓÐ21È˻ظ´
¡¾ÇóÖú¡¿¶ÔÕÕÆ·±ê¶¨
ÒѾÓÐ8È˻ظ´
¡¾ÇóÖú¡¿Çë½Ì£ºÆøÏà ·å²»ÄÜÍêÈ«·ÖÀëÔõô»ØÊ£¿
ÒѾÓÐ11È˻ظ´
¡¾ÌÖÂÛ¡¿¶ÔÕÕÆ·º¬Á¿ÎÊÌâ
ÒѾÓÐ8È˻ظ´

СÀÇ851226
ľ³æ (ÕýʽдÊÖ)
- DRDEPI: 1
- Ó¦Öú: 167 (¸ßÖÐÉú)
- ½ð±Ò: 2431.2
- ºì»¨: 20
- Ìû×Ó: 789
- ÔÚÏß: 537.3Сʱ
- ³æºÅ: 1437027
- ×¢²á: 2011-10-11
- ÐÔ±ð: GG
- רҵ: ºÏ³ÉÒ©Îﻯѧ
8Â¥2013-04-19 08:54:43
yanjp
¾èÖú¹ó±ö (ÖøÃûдÊÖ)
- DRDEPI: 1
- Ó¦Öú: 32 (СѧÉú)
- ½ð±Ò: 2681.2
- É¢½ð: 2
- ºì»¨: 36
- Ìû×Ó: 1313
- ÔÚÏß: 43.1Сʱ
- ³æºÅ: 422836
- ×¢²á: 2007-07-17
- ÐÔ±ð: GG
- רҵ: Ò©ÎïѧÆäËû¿ÆÑ§ÎÊÌâ
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¡ï ¡ï ¡ï ¡ï
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
News: ½ð±Ò+2, ¡ï¡ï¡ïºÜÓаïÖú, ÎÒÃÇÂòµÄÊǺ¬Á¿¶ÔÕÕÆ·£¬²»ÊÇÔÓÖʶÔÕÕÆ·£¬ÄãÌṩµÄ×ÊÁÏÀïÃæÃ»ÓÐÌá¼°ÎÒÓöµ½µÄÎÊÌâ¡£²»ÖªµÀ£¬Ä㻹ÓÐʲô×ÊÁϿɹ©²Î¿¼£¿Ð»Ð» 2013-04-17 15:23:14
zhychen2008: ½ð±Ò+2, ¸Ðл»ØÌû½»Á÷ 2013-04-17 23:46:17
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
News: ½ð±Ò+2, ¡ï¡ï¡ïºÜÓаïÖú, ÎÒÃÇÂòµÄÊǺ¬Á¿¶ÔÕÕÆ·£¬²»ÊÇÔÓÖʶÔÕÕÆ·£¬ÄãÌṩµÄ×ÊÁÏÀïÃæÃ»ÓÐÌá¼°ÎÒÓöµ½µÄÎÊÌâ¡£²»ÖªµÀ£¬Ä㻹ÓÐʲô×ÊÁϿɹ©²Î¿¼£¿Ð»Ð» 2013-04-17 15:23:14
zhychen2008: ½ð±Ò+2, ¸Ðл»ØÌû½»Á÷ 2013-04-17 23:46:17
|
http://www.edqm.eu/en/EDQM-FAQ-a ... 0.html?rubrique=468 01. How can I find out the purity of a Ph. Eur. CRS? The assigned content of a CRS is given in the online search catalogue and on the CRS label, when it is required to calculate the content using the prescribed test and/or assay of a prevailing European Pharmacopoeia monograph. In other cases, values are not assigned and it cannot be assumed that the purity is 100%. However, the purity of an impurity CRS, can be assumed to be 100% for the test for related substances of the prevailing European Pharmacopoeia monograph, if the purity is not indicated. The assigned content of lyophilised preparations may be expressed as mass of pure substance per vial (eg mg/vial) or potency per vial (eg IU units/vial). |
2Â¥2013-04-17 14:29:36
csc_0769
ľ³æ (ÖøÃûдÊÖ)
- Ó¦Öú: 202 (´óѧÉú)
- ½ð±Ò: 3221.4
- É¢½ð: 66
- ºì»¨: 16
- Ìû×Ó: 1793
- ÔÚÏß: 528.5Сʱ
- ³æºÅ: 1322860
- ×¢²á: 2011-06-14
- ÐÔ±ð: GG
- רҵ: Ò©Îï·ÖÎö
3Â¥2013-04-17 17:39:07
News
ר¼Ò¹ËÎÊ (Ö°Òµ×÷¼Ò)
- DRDEPI: 6
- Ó¦Öú: 366 (˶ʿ)
- ¹ó±ö: 0.025
- ½ð±Ò: 5971.2
- É¢½ð: 3206
- ºì»¨: 155
- ɳ·¢: 24
- Ìû×Ó: 4826
- ÔÚÏß: 677.4Сʱ
- ³æºÅ: 1205015
- ×¢²á: 2011-02-17
- ÐÔ±ð: GG
- רҵ: É«Æ×·ÖÎö
- ¹ÜϽ: ÉúÎïÒ½Ò©Çø

4Â¥2013-04-17 21:08:49













»Ø¸´´ËÂ¥